RT Journal Article
SR Electronic
T1 Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.20.21265137
DO 10.1101/2021.10.20.21265137
A1 Katherine J. Siddle
A1 Lydia A. Krasilnikova
A1 Gage K. Moreno
A1 Stephen F. Schaffner
A1 Johanna Vostok
A1 Nicholas A. Fitzgerald
A1 Jacob E. Lemieux
A1 Nikolaos Barkas
A1 Christine Loreth
A1 Ivan Specht
A1 Christopher H. Tomkins-Tinch
A1 Jillian Silbert
A1 Beau Schaeffer
A1 Bradford P. Taylor
A1 Bryn Loftness
A1 Hillary Johnson
A1 Petra L. Schubert
A1 Hanna M. Shephard
A1 Matthew Doucette
A1 Timelia Fink
A1 Andrew S. Lang
A1 Stephanie Baez
A1 John Beauchamp
A1 Scott Hennigan
A1 Erika Buzby
A1 Stephanie Ash
A1 Jessica Brown
A1 Selina Clancy
A1 Seana Cofsky
A1 Luc Gagne
A1 Joshua Hall
A1 Rachel Harrington
A1 Gabrielle L. Gionet
A1 Katherine C. DeRuff
A1 Megan E. Vodzak
A1 Gordon C. Adams
A1 Sabrina T. Dobbins
A1 Sarah D. Slack
A1 Steven K. Reilly
A1 Lisa M. Anderson
A1 Michelle C. Cipicchio
A1 Matthew T. DeFelice
A1 Jonna L. Grimsby
A1 Scott E. Anderson
A1 Brendan S. Blumenstiel
A1 James C. Meldrim
A1 Heather M. Rooke
A1 Gina Vicente
A1 Natasha L. Smith
A1 Katelyn S. Messer
A1 Faye L. Reagan
A1 Zoe M. Mandese
A1 Matthew D. Lee
A1 Marianne C. Ray
A1 Marissa E. Fisher
A1 Maesha A. Ulcena
A1 Corey M. Nolet
A1 Sean E. English
A1 Katie L. Larkin
A1 Kyle Vernest
A1 Sushma Chaluvadi
A1 Deirdre Arvidson
A1 Maurice Melchiono
A1 Theresa Covell
A1 Vaira Harik
A1 Taylor Brock-Fisher
A1 Molly Dunn
A1 Amanda Kearns
A1 William P. Hanage
A1 Clare Bernard
A1 Anthony Philippakis
A1 Niall J Lennon
A1 Stacey B. Gabriel
A1 Glen R. Gallagher
A1 Sandra Smole
A1 Lawrence C. Madoff
A1 Catherine M. Brown
A1 Daniel J. Park
A1 Bronwyn L. MacInnis
A1 Pardis C. Sabeti
YR 2021
UL http://medrxiv.org/content/early/2021/10/20/2021.10.20.21265137.abstract
AB Multiple summer events, including large indoor gatherings, in Provincetown, Massachusetts (MA), in July 2021 contributed to an outbreak of over one thousand COVID-19 cases among residents and visitors. Most cases were fully vaccinated, many of whom were also symptomatic, prompting a comprehensive public health response, motivating changes to national masking recommendations, and raising questions about infection and transmission among vaccinated individuals. To characterize the outbreak and the viral population underlying it, we combined genomic and epidemiological data from 467 individuals, including 40% of known outbreak-associated cases. The Delta variant accounted for 99% of sequenced outbreak-associated cases. Phylogenetic analysis suggests over 40 sources of Delta in the dataset, with one responsible for a single cluster containing 83% of outbreak-associated genomes. This cluster was likely not the result of extensive spread at a single site, but rather transmission from a common source across multiple settings over a short time. Genomic and epidemiological data combined provide strong support for 25 transmission events from, including many between, fully vaccinated individuals; genomic data alone provides evidence for an additional 64. Together, genomic epidemiology provides a high-resolution picture of the Provincetown outbreak, revealing multiple cases of transmission of Delta from fully vaccinated individuals. However, despite its magnitude, the outbreak was restricted in its onward impact in MA and the US, likely due to high vaccination rates and a robust public health response.Competing Interest StatementCompeting interests: P.C.S. is a co-founder of, shareholder in, and scientific advisor to Sherlock Biosciences, Inc., as well as a Board member of and shareholder in Danaher Corporation. J.E.L. has received consulting fees from Sherlock Biosciences. A.P. is a Venture Partner at Google Ventures. Other authors report no competing interests.Funding StatementThis work was sponsored by the Centers for Disease Control and Prevention COVID-19 baseline genomic surveillance contract sequencing (75D30121C10501 to Clinical Research Sequencing Platform, LLC), a CDC Broad Agency Announcement (75D30120C09605 to B.L.M), National Institute of Allergy and Infectious Diseases (U19AI110818 and U01 AI151812 to P.C.S.), the Rockefeller Foundation (2021HTH013 to B.L.M. and P.C.S.), and the Bill and Melinda Gates Foundation (INV-002717 to B.L.M.), as well as support from the Doris Duke Charitable Foundation (J.E.L.), the Howard Hughes Medical Institute (P.C.S.), and the National Human Genome Research Institute (K99HG010669 to S.K.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was reviewed and approved by the Massachusetts Department of Public Health Institutional Review Board and covered by a reliance agreement at the Broad Institute. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe deposited genomes (Genbank), metadata (BioSample), and raw reads (SRA) to NCBI under BioProject PRJNA715749. All genomes produced in the present study are also available on GISAID.